Skip to main content

Table 1 National Cancer Institute Common Terminology Criteria for Adverse Events v4.0 “Oral mucositis”

From: Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study

Grade 1

Grade 2

Grade 3

Grade 4

Grade 5

Asymptomatic or mild symptoms; intervention not indicated

Moderate pain; not interfering with oral intake; modified diet indicated

Severe pain; interfering with oral intake

Life-threatening consequence; urgent intervention indicated

Death